Anthony Gallea spent 45 years earning the trust of other financial professionals and colleagues. With his corporate responsibilities now complete, he offers insight, analysis, and the kind of perspective that only comes from decades of experience.
Anthony Gallea spent 45 years earning the trust of other financial professionals and colleagues. With his corporate responsibilities now complete, he offers insight, analysis, and the kind of perspective that only comes from decades of experience.
Commentary from a trusted advisor on actionable market opportunities.
Commentary from a trusted advisor on markets, media, and modern life.
What’s Inside Working Profit
What’s Inside Working Profit
Concise, unscheduled insights as conditions change—helping you stay grounded when markets don’t.
WEEKLY STOCK NEWS SUMMARIES (WPIL)
THE WORKING PROFIT INVESTMENT LETTER (WPIL)
PERIODIC MARKET UPDATES (WPIL)
Timely breakdowns of earnings, company developments, and market-moving trends—focused on what actually matters for investors.
A paid monthly publication where Tony shares deeper analysis, portfolio insights, and his broader perspective on the markets, opportunities, and risks he’s watching closely.
The Working Profit Investment Letter is a premium monthly publication.
Subscribers receive in-depth market analysis, portfolio insights, and thoughtful commentary on the opportunities, risks, and trends shaping today’s financial landscape.
Membership also includes Weekly Stock News Summaries, periodic market bulletins, and ongoing research tied to the WPIL Large Cap Activist and WPIL Biotech Pharma portfolios.
Built for investors seeking long-term perspective beyond headlines and market noise.
The Working Profit Investment Letter is a premium monthly publication.
Subscribers receive in-depth market analysis, portfolio insights, and thoughtful commentary on the opportunities, risks, and trends shaping today’s financial landscape.
Membership also includes Weekly Stock News Summaries, periodic market bulletins, and ongoing research tied to the WPIL Large Cap Activist and WPIL Biotech Pharma portfolios.
Built for investors seeking long-term perspective beyond headlines and market noise.
The investment letter
